FATE: Nilai perusahaan marang bathi resik Fate Therapeutics Inc

Fate Therapeutics Inc - logo grafis emiten FATE

Immunotherapy developer Fate Therapeutics, Inc. (FATE) relies on the stability of Western biotech, while the current market quotes visualized below account for the impact of genetic sovereignty and trade restrictions. The indicator stands at -1.20. Business prospects depend on the efficiency of iPSC technologies and partnerships with corporate behemoths. Operational continuity is ensured through a strict temperature regime during the air transport of biomaterials.

Koefisien rega marang bathi: Fate Therapeutics, Inc. (FATE) kanggo 04.07.2022 - 14.11.2026

Rincian metrik komprehensif lan analitis Fate Therapeutics Corp (FATE)

- rega saham lan prakiraan rega para ahli:
Bagan owah-owahan rega fatetherapeutics.com|FATE - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Fate Therapeutics, Inc.|FATE - Nilai Perusahaan
- indikator nilai aset resik miturut neraca:
Nilai Akuntansi saben Saham Fate Therapeutics|FATE - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku fatetherapeutics.com|FATE - Aset Agregat Perusahaan
- informasi babagan utang lan solvabilitas:
Rasio Kabeh Utang marang Dana Pribadi Fate Therapeutics, Inc.|FATE - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Fate Pharma|FATE - Gunggung utang perusahaan|Rasio utang-utang marang kapitalisasi buku Fate Therapeutics, Inc.|FATE - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Fate Therapeutics|Rasio likuiditas perantara fatetherapeutics.com
- indikator profitabilitas perusahaan lan kelipatan valuasi:
FATE - Bathi resik|Bathi resik sing dikarepake Fate Therapeutics, Inc.|FATE - Koefisien rega marang bathi|Pangali mangsa ngarep rega marang bathi Fate Therapeutics Inc|FATE - Pangali rega marang bathi tumrap wutah|Koefisien nilai perusahaan marang bathi operasional sadurunge panyusutan Fate Therapeutics, Inc.|FATE - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Fate Therapeutics|FATE - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan fatetherapeutics.com|FATE - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Fate Therapeutics, Inc.
- rincian pendapatan lan dodolan emiten:
FATE - Pendapatan lan volume dodolan|Prakiraan volume dodolan fatetherapeutics.com|FATE - Rasio rega marang pendapatan|Rega mangsa ngarep marang pendapatan Fate Therapeutics, Inc.
Ringkesan analisis perusahaan:fatetherapeutics.com (FATE)
Barang unggulan Fate Therapeutics

Professional asset selection is based on filtering securities with unjustifiably high valuations relative to their earnings. This price-to-earnings ratio measures the market price of a single share divided by the company's net income per share. Analyzing this indicator allows for the separation of speculative spikes from real business growth. For Fate Therapeutics, Inc. (FATE), a high valuation is justified by the ownership of unique patents in the field of stem cell therapy.

Pesaing wigati

ONC: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Nilai perusahaan marang bathi resik|Pangali P/E AAPG (Ascentage)|CGON - Koefisien rega marang bathi|URGN: Koefisien rega marang bathi|BCAX - Pangali P/E|Personalis (PSNL) - Rasio rega marang bathi|Erasca Inc - Nilai perusahaan marang bathi resik|DCTH (Delcath) - Pangali P/E|Kapitalisasi marang bathi Y-mAbs Corp YMAB|Pangali P/E AURA|CADL: Kapitalisasi marang bathi resik|Pangali P/E ARAY (Accuray)|Pangali P/E SELLAS Life Sciences Group, Inc. SLS|ACTU: Koefisien rega marang bathi|Citius Oncology Inc - Rasio rega pasar marang bathi resik|HURA: Pangali P/E|Kapitalisasi marang bathi protaratx.com (TARA)|Koefisien rega marang bathi WHWK|TCRX: Nilai perusahaan marang bathi resik|Koefisien rega marang bathi CSBR (Champions Oncology)|Rasio rega pasar marang bathi resik XBIT|Pangali P/E CVM (CEL-SCI)|Nilai perusahaan marang bathi resik OSTX|Radiopharm Theranostics - Pangali P/E|Kapitalisasi marang bathi Artiva Biotherapeutics, Inc.|adlainortye.com (ANL) - Rasio rega marang bathi|Veru Corporation - Nilai perusahaan marang bathi resik|TPST (Tempest Therapeutics) - Pangali P/E|Pangali P/E Xilio|Rasio rega marang bathi Renovaro Inc. (RENB)|MURA: Kapitalisasi marang bathi resik|Pangali P/E KAPA (Kairos Pharma)|OnKure Therapeutics, Inc. (OKUR) - Kapitalisasi marang bathi|GDTC: Koefisien rega marang bathi|CRIS - Pangali P/E|APLM (apollomicsinc.com) - Koefisien rega marang bathi|THAR: Rasio rega pasar marang bathi resik|ADVB (Advanced Biomed Inc.) - Pangali P/E|Genprex Inc (GNPX) - Periode bali modal bisnis|Pangali P/E CLDI|Koefisien rega marang bathi sunshinebiopharma.com SBFM|Rasio rega marang bathi Xenetic Biosciences, Inc. XBIO|Periode bali modal bisnis Salarius Pharmaceuticals Inc (SLRX)|PPBT: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik AONC (American Oncology Network)|BGNE: Pangali P/E|CKPT - Periode bali modal bisnis|Rasio rega marang bathi Elevation Oncology|Pangali rega marang bathi ICAD (iCAD Corp)|Pangali P/E IKNA|Koefisien rega marang bathi Notable Labs Corp NTBL|Viracta Therapeutics, Inc. - Koefisien rega marang bathi|Periode bali modal bisnis morphosys.com (MOR)|NAYA Biosciences Inc. - Pangali P/E|Kapitalisasi marang bathi resik AAPGV